Chambers Review
Provided by Chambers
Asia
Capital Markets - South Korea
Individual Editorial
Haeng-Gyu Lee leads Jipyong's capital markets practice. He frequently advises Korean companies on their IPOs on the KOSDAQ and KOSPI.
Email address
[email protected]Contact number
+82 2 6200 1744Share profile
Band 3
Provided by Haeng-Gyu Lee
Capital Markets; Private Equity; M&A
Mr. Haeng Gyu Lee leads Jipyong’s capital markets practice and is a partner in the firm’s Finance Group.
Mr. Lee is one of Korea’s highest-ranking attorneys in capital markets practice (IPOs and de-listing reviews), private equity funds, M&A and overseas expansion of financial institutions, with unparalleled experience in cross-border IPOs, ADR, GDR offerings and dual listings.
Mr. Lee is expected to represent unrivaled base of underwriters and issuers in connection with around twenty IPOs on the KOSPI Market and the KOSDAQ Market of the Korea Exchange (KRX) in 2022. He was involved in some twenty-five IPOs in 2021. Mr Lee is also renowned for his novelty in advising numerous foreign companies such as Prestige BioPharma (Singapore), New Pride Corporation (US), Kolao Holdings (Laos), Fast Future Brands (Australia) and LS Cable & System Asia (Vietnam) on their pioneering listing on the KRX.
Korean Bar; New York Bar
Columbia Law School (LL.M., 2007);
Seoul National University (LL.B., 1996)
Provided by Chambers
Haeng-Gyu Lee leads Jipyong's capital markets practice. He frequently advises Korean companies on their IPOs on the KOSDAQ and KOSPI.